ctDNA as a cancer biomarker: A broad overview
Open accessThe DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Abstract
Circulating tumor DNA (ctDNA) in fluids has gained attention because ctDNA seems to identify tumor-specific abnormalities, which could be used for diagnosis, follow-up of treatment, and prognosis: the so-called liquid biopsy. Liquid biopsy is a minimally invasive approach and presents the sum of ctDNA from primary and secondary tumor sites. It has been possible not only to quantify the amount of ctDNA but also to identify (epi)genetic changes. Specific mutations in genes have been identified in the plasma of patients with several types of cancer, which highlights ctDNA as a possible cancer biomarker. However, achieving detectable concentrations of ctDNA in body fluids is not an easy task. ctDNA fragments present a short half-life, and there are no cut-off values to discriminate high and low ctDNA concentrations. Here, we discuss the use of ctDNA as a cancer biomarker, the main methodologies, the inherent difficulties, and the clinical predictive value of ctDNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
(2014) · Climate Change 2013 – The Physical Science Basis · doi:10.1017/cbo9781107415324.004 · Cited by 23,880
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, F. A., He, Y., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612674 · Cited by 3,379
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
Ramalingam, S. S., Vansteenkiste, J., Planchard, D., Cho, B. C., Gray, J. E., Ohe, Y., Zhou, C., Reungwetwattana, T., Cheng, Y., Chewaskulyong, B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1913662 · Cited by 2,914
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
High-throughput droplet digital PCR system for absolute quantitation of DNA copy number
Hindson, B. J., Ness, K. D., Masquelier, D. A., Belgrader, P., Heredia, N. J., Makarewicz, A. J., Bright, I. J., Lucero, M. Y., Hiddessen, A. L., Legler, T. C., et al. (2011) · Analytical Chemistry · doi:10.1021/ac202028g · Cited by 2,792
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220 · cited 2×
“Different improved NGS technologies, such as the Safe-Sequencing System (Safe-Seq) (Kinde et al., 2011) and Cancer Personalized Profiling by deep sequencing (CAPP-seq) (Newman et al., 2014), have allowed greatly improved detection sensitivity of ctDNA.”
BackgroundMethodLiquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
(1977) · PubMed · Cited by 1,801
Vogelstein, B., & Kinzler, K. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9236 · Cited by 1,770
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.011 · Cited by 1,495
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1483 · Cited by 1,394
Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J., Chirieac, L. R., D'Amico, T. A., DeCamp, M. M., Dilling, T. J., Dobelbower, M., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0050 · Cited by 1,303
Kim, E. S., Hirsh, V., Mok, T., Socinski, M. A., Gervais, R., Wu, Y.-L., Li, L.-Y., Watkins, C. L., Sellers, M. V., Lowe, E. S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61758-4 · Cited by 1,242
Nuclear Acids In Human Blood Plasma.
Mandel, P., & Métais, P. (1948) · PubMed · Cited by 1,196
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Detection and quantification of rare mutations with massively parallel sequencing
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,144
Direct detection of early-stage cancers using circulating tumor DNA
Phallen, J., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,119
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Witkiewicz, A. K., McMillan, E. A., Balaji, U., Baek, G., Lin, W.-C., Mansour, J., Mollaee, M., Wagner, K.-U., Koduru, P., Yopp, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7744 · Cited by 1,115
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., Lindeman, N., Lockwood, C. M., Rai, A. J., Schilsky, R. L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8671 · Cited by 959
Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0388-cp · Cited by 936
Science Translational Medicine
(2013) · Science Translational Medicine · doi:10.1126/scitranslmed · Cited by 859
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818 · cited 3×
“these origins: apoptosis, necrosis, phagocytosis, oncosis and active secretion for particular structures (Aucamp et al., 2018; Thierry et al., 2016).”
BackgroundLengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Jiang, P., Chan, C. W. M., Chan, K. C. A., Cheng, S. H., Wong, J., Wong, V. W.-S., Wong, G. L. H., Chan, S. L., Mok, T. S. K., Chan, H. L. Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500076112 · Cited by 738
Wu, Y.-L., Zhou, C., Liam, C.-K., Wu, G., Liu, X., Zhong, Z., Lu, S., Cheng, Y., Han, B., Chen, L., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv270 · Cited by 738
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
Stroun, M., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Beljanski, M. (2009) · Oncology · doi:10.1159/000226740 · Cited by 733
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
Fribbens, C., O’Leary, B., Kilburn, L., Hrebien, S., Garcia-Murillas, I., Beaney, M., Cristofanilli, M., Andre, F., Loi, S., Loibl, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.3061 · Cited by 722
Integrating genomic features for non-invasive early lung cancer detection
Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., Schroers-Martin, J., Nabet, B. Y., Chen, B., Chaudhuri, A. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2140-0 · Cited by 685
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Rolfo, C., Mack, P. C., Scagliotti, G. V., Baas, P., Barlesi, F., Bivona, T. G., Herbst, R. S., Mok, T. S., Peled, N., Pirker, R., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.030 · Cited by 660
Goss, G., Tsai, C.-M., Shepherd, F. A., Bazhenova, L., Lee, J. S., Chang, G.-C., Crino, L., Satouchi, M., Chu, Q., Hida, T., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30508-3 · Cited by 645
Life and death of circulating cell-free DNA
Kustanovich, A., Schwartz, R., Peretz, T., & Grinshpun, A. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1598759 · Cited by 606
Harding, J. J., Nandakumar, S., Armenia, J., Khalil, D. N., Albano, M., Ly, M., Shia, J., Hechtman, J. F., Kundra, R., El Dika, I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2293 · Cited by 602 · cited 1×
“Another study showed that HCC tumors harboring oncogenic PI3K-mTOR mutations had worse outcomes on sorafenib treatment, while the presence of activating WNT/b-catenin alterations was associated with innate resistance to immune checkpoint inhibitors (Harding et al., 2019).”
BackgroundLeighl, N. B., Page, R. D., Raymond, V. M., Daniel, D. B., Divers, S. G., Reckamp, K. L., Villalona-Calero, M. A., Dix, D., Odegaard, J. I., Lanman, R. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0624 · Cited by 587
Yang, J. C.-H., Ahn, M.-J., Kim, D.-W., Ramalingam, S. S., Sequist, L. V., Su, W.-C., Kim, S.-W., Kim, J.-H., Planchard, D., Felip, E., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.3223 · Cited by 571
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Mouliere, F., Robert, B., Arnau Peyrotte, E., Del Rio, M., Ychou, M., Molina, F., Gongora, C., & Thierry, A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023418 · Cited by 567
The emerging role of cell-free DNA as a molecular marker for cancer management
Bronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2019.100087 · Cited by 566
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Chen, M., & Zhao, H. (2019) · Human Genomics · doi:10.1186/s40246-019-0220-8 · Cited by 556
Soluble normal and mutated DNA sequences from single-copy genes in human blood.
Sorenson, G. D., Pribish, D. M., Valone, F. H., Memoli, V. A., Bzik, D. J., & Yao, S. (1994) · PubMed · Cited by 530
Wang, Y., Springer, S., Mulvey, C. L., Silliman, N., Schaefer, J., Sausen, M., James, N., Rettig, E. M., Guo, T., Pickering, C. R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8507 · Cited by 500
BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
Diehl, F., Li, M., He, Y., Kinzler, K. W., Vogelstein, B., & Dressman, D. (2006) · Nature Methods · doi:10.1038/nmeth898 · Cited by 496
Thress, K. S., Brant, R., Carr, T. H., Dearden, S., Jenkins, S., Brown, H., Hammett, T., Cantarini, M., & Barrett, J. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.004 · Cited by 493
Aggarwal, C., Thompson, J. C., Black, T. A., Katz, S. I., Fan, R., Yee, S. S., Chien, A. L., Evans, T. L., Bauml, J. M., Alley, E. W., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4305 · Cited by 486
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Reinert, T., Schøler, L. V., Thomsen, R., Tobiasen, H., Vang, S., Nordentoft, I., Lamy, P., Kannerup, A.-S., Mortensen, F. V., Stribolt, K., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308859 · Cited by 463
Olsson, E., Winter, C., George, A., Chen, Y., Howlin, J., Tang, M. E., Dahlgren, M., Schulz, R., Grabau, D., van Westen, D., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404913 · Cited by 453
Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
Abbosh, C., Birkbak, N. J., & Swanton, C. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0058-3 · Cited by 450
Plasma AR and abiraterone-resistant prostate cancer
Romanel, A., Tandefelt, D. G., Conteduca, V., Jayaram, A., Casiraghi, N., Wetterskog, D., Salvi, S., Amadori, D., Zafeiriou, Z., Rescigno, P., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9511 · Cited by 441
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Warren, J. D., Xiong, W., Bunker, A. M., Vaughn, C. P., Furtado, L. V., Roberts, W. L., Fang, J. C., Samowitz, W. S., & Heichman, K. A. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-133 · Cited by 438
Cremolini, C., Rossini, D., Dell’Aquila, E., Lonardi, S., Conca, E., Del Re, M., Busico, A., Pietrantonio, F., Danesi, R., Aprile, G., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5080 · Cited by 424
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Palmirotta, R., Lovero, D., Cafforio, P., Felici, C., Mannavola, F., Pellè, E., Quaresmini, D., Tucci, M., & Silvestris, F. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918794630 · Cited by 423
Vasioukhin, V., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Stroun, M. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04828.x · Cited by 414
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
Cheng, F., Su, L., & Qian, C. (2016) · Oncotarget · doi:10.18632/oncotarget.9453 · Cited by 406
Shapiro, B., Chakrabarty, M., Cohn, E. M., & Leon, S. A. (1983) · Cancer · doi:10.1002/1097-0142(19830601)51:11<2116::aid-cncr2820511127>3.0.co;2-s · Cited by 403
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Beaver, J. A., Jelovac, D., Balukrishna, S., Cochran, R. L., Croessmann, S., Zabransky, D. J., Wong, H. Y., Valda Toro, P., Cidado, J., Blair, B. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2933 · Cited by 398
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Elazezy, M., & Joosse, S. A. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.10.002 · Cited by 370
How liquid biopsies can change clinical practice in oncology
Siravegna, G., Mussolin, B., Venesio, T., Marsoni, S., Seoane, J., Dive, C., Papadopoulos, N., Kopetz, S., Corcoran, R. B., Siu, L. L., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz227 · Cited by 358
Platelets actively sequester angiogenesis regulators
Lakka Klement, G., Yip, T.-T., Cassiola, F., Kikuchi, L., Cervi, D., Podust, V., Italiano, J. E., Wheatley, E., Abou-Slaybi, A., Bender, E., et al. (2009) · Blood · doi:10.1182/blood-2008-06-159541 · Cited by 346
Tailoring to RB: tumour suppressor status and therapeutic response
Knudsen, E. S., & Knudsen, K. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2401 · Cited by 344
Vidal, J., Muinelo, L., Dalmases, A., Jones, F., Edelstein, D., Iglesias, M., Orrillo, M., Abalo, A., Rodríguez, C., Brozos, E., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx125 · Cited by 344
Tumor clone dynamics in lethal prostate cancer
Carreira, S., Romanel, A., Goodall, J., Grist, E., Ferraldeschi, R., Miranda, S., Prandi, D., Lorente, D., Frenel, J.-S., Pezaro, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009448 · Cited by 340
Liquid biopsy in breast cancer: A comprehensive review
Alimirzaie, S., Bagherzadeh, M., & Akbari, M. R. (2019) · Clinical Genetics · doi:10.1111/cge.13514 · Cited by 332
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S., & Pretorius, P. J. (2018) · Biological Reviews · doi:10.1111/brv.12413 · Cited by 317
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Schøler, L. V., Reinert, T., Ørntoft, M.-B. W., Kassentoft, C. G., Árnadóttir, S. S., Vang, S., Nordentoft, I., Knudsen, M., Lamy, P., Andreasen, D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0510 · Cited by 306
Best, M. G., Wesseling, P., & Wurdinger, T. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0887 · Cited by 297
EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistance
Wang, S., Song, Y., & Liu, D. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.11.008 · Cited by 293
Circulating biomarkers for early detection and clinical management of colorectal cancer
Marcuello, M., Vymetalkova, V., Neves, R. P. L., Duran-Sanchon, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., Garcia-Barberan, V., Fijneman, R. J., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.002 · Cited by 275
Kwapisz, D. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.32 · Cited by 271
Conteduca, V., Wetterskog, D., Sharabiani, M. T. A., Grande, E., Fernandez-Perez, M. P., Jayaram, A., Salvi, S., Castellano, D., Romanel, A., Lolli, C., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx155 · Cited by 269
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Fiala, C., & Diamandis, E. P. (2018) · BMC Medicine · doi:10.1186/s12916-018-1157-9 · Cited by 269
Weigelt, B., Comino-Méndez, I., de Bruijn, I., Tian, L., Meisel, J. L., García-Murillas, I., Fribbens, C., Cutts, R., Martelotto, L. G., Ng, C. K. Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0544 · Cited by 263
Postel, M., Roosen, A., Laurent-Puig, P., Taly, V., & Wang-Renault, S.-F. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1400384 · Cited by 254
Circulating biomarkers in patients with glioblastoma
Müller Bark, J., Kulasinghe, A., Chua, B., Day, B. W., & Punyadeera, C. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0603-6 · Cited by 252
Garlan, F., Laurent-Puig, P., Sefrioui, D., Siauve, N., Didelot, A., Sarafan-Vasseur, N., Michel, P., Perkins, G., Mulot, C., Blons, H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3155 · Cited by 250
Yu, S. C., Lee, S. W., Jiang, P., Leung, T. Y., Chan, K. A., Chiu, R. W., & Lo, Y. D. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.203679 · Cited by 242
Yao, W., Mei, C., Nan, X., & Hui, L. (2016) · Gene · doi:10.1016/j.gene.2016.06.033 · Cited by 235
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.
Anker, P., Stroun, M., & Maurice, P. A. (1975) · PubMed · Cited by 234
Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
Zhang, W., Xia, W., Lv, Z., Ni, C., Xin, Y., & Yang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000458736 · Cited by 229
Couraud, S., Vaca-Paniagua, F., Villar, S., Oliver, J., Schuster, T., Blanché, H., Girard, N., Trédaniel, J., Guilleminault, L., Gervais, R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3063 · Cited by 215
Volckmar, A., Sültmann, H., Riediger, A., Fioretos, T., Schirmacher, P., Endris, V., Stenzinger, A., & Dietz, S. (2018) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22517 · Cited by 207
Khagi, Y., Goodman, A. M., Daniels, G. A., Patel, S. P., Sacco, A. G., Randall, J. M., Bazhenova, L. A., & Kurzrock, R. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1439 · Cited by 202
Characterization of the cell-free DNA released by cultured cancer cells
Bronkhorst, A. J., Wentzel, J. F., Aucamp, J., van Dyk, E., du Plessis, L., & Pretorius, P. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.022 · Cited by 182
Brown, D., Smeets, D., Székely, B., Larsimont, D., Szász, A. M., Adnet, P.-Y., Rothé, F., Rouas, G., Nagy, Z. I., Faragó, Z., et al. (2017) · Nature Communications · doi:10.1038/ncomms14944 · Cited by 178
Blood clearance kinetics and liver uptake of mononucleosomes in mice
Gauthier, V. J., Tyler, L. N., & Mannik, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1151 · Cited by 175
Circulating Nucleic Acids and Apoptosis
LICHTENSTEIN, A. V., MELKONYAN, H. S., TOMEI, L. D., & UMANSKY, S. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03892.x · Cited by 172
Piccioni, D. E., Achrol, A. S., Kiedrowski, L. A., Banks, K. C., Boucher, N., Barkhoudarian, G., Kelly, D. F., Juarez, T., Lanman, R. B., Raymond, V. M., et al. (2019) · CNS Oncology · doi:10.2217/cns-2018-0015 · Cited by 170
Kuznetsov, H. S., Marsh, T., Markens, B. A., Castaño, Z., Greene-Colozzi, A., Hay, S. A., Brown, V. E., Richardson, A. L., Signoretti, S., Battinelli, E. M., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0216 · Cited by 168
Mastoraki, S., Strati, A. D., Tzanikou, E., Chimonidou, M., Politaki, E., Voutsina, A., Psyrri, A. K., Georgoulias, V., & Lianidou, E. S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1181 · Cited by 168
Wang, J., Hsieh, J., Chang, M., Huang, T., Chen, F., Cheng, T., Alexandersen, K., Huang, Y., Tzou, W., & Lin, S. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7366-8 · Cited by 167
Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis
Wu, J., Hu, S., Zhang, L., Xin, J., Sun, C., Wang, L., Ding, K., & Wang, B. (2020) · Theranostics · doi:10.7150/thno.40532 · Cited by 167
Karapetis, C. S., Jonker, D., Daneshmand, M., Hanson, J. E., O'Callaghan, C. J., Marginean, C., Zalcberg, J. R., Simes, J., Moore, M. J., Tebbutt, N. C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0606 · Cited by 159
Afrăsânie, V.-A., Marinca, M. V., Alexa-Stratulat, T., Gafton, B., Păduraru, M., Adavidoaiei, A. M., Miron, L., & Rusu, C. (2019) · Radiology and Oncology · doi:10.2478/raon-2019-0033 · Cited by 159
Tjensvoll, K., Lapin, M., Buhl, T., Oltedal, S., Steen-Ottosen Berry, K., Gilje, B., Søreide, J. A., Javle, M., Nordgård, O., & Smaaland, R. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.11.012 · Cited by 154
Rolfo, C. D., Cardona, A. F., Cristofanilli, M., Paz-Ares, L. G., Díaz‐Mochon, J. J., Durán, I., Raez, L. E., Russo, A., Lorente, J. A., Malapelle, U., et al. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102978 · Cited by 152
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations
Castro-Giner, F., Gkountela, S., Donato, C., Alborelli, I., Quagliata, L., Ng, C. K. Y., Piscuoglio, S., & Aceto, N. (2018) · Diagnostics · doi:10.3390/diagnostics8020031 · Cited by 150
Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity
Dagogo-Jack, I., Rooney, M., Lin, J. J., Nagy, R. J., Yeap, B. Y., Hubbeling, H., Chin, E., Ackil, J., Farago, A. F., Hata, A. N., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1436 · Cited by 149
Mathai, R. A., Vidya, R. V. S., Reddy, B. S., Thomas, L., Udupa, K., Kolesar, J., & Rao, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030373 · Cited by 148
Liquid biopsy for lung cancer early detection
Santarpía, M., Liguori, A., D’Aveni, A., Karachaliou, N., González‐Cao, M., Daffinà, M. G., Lazzari, C., Altavilla, G., & Rosell, R. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.03.81 · Cited by 145
Maire, F., Micard, S., Hammel, P. R., Voitot, H., Lévy, P., Cugnenc, P., Ruszniewski, P. B., & Laurent‐Puig, P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600475 · Cited by 142
Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer
Mattos‐Arruda, L. D., & Caldas, C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.001 · Cited by 141
Circulating Nucleic Acids in Plasma and Serum
Swaminathan, R., & Butt, A. N. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.001 · Cited by 141
Lousada-Fernandez, F., Rapado‐González, Ó., López-Cedrún, J. L., López‐López, R., Muinelo‐Romay, L., & Suárez‐Cunqueiro, M. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061704 · Cited by 139
The virtosome—a novel cytosolic informative entity and intercellular messenger
Gahan, P. B., & Stroun, M. (2010) · Cell Biochemistry and Function · doi:10.1002/cbf.1690 · Cited by 136
The value of cell‐free DNA for molecular pathology
Stewart, C. M., Kothari, P. D., Mouliere, F. C., Mair, R. J., Somnay, S., Benayed, R., Zehir, A., Weigelt, B., Dawson, S., Arcila, M. E., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5048 · Cited by 134
The dawn of the liquid biopsy in the fight against cancer
Domínguez-Vigil, I. G., Moreno-Martínez, A. K., Wang, J. Y., Roehrl, M. H. A., & Barrera-Saldaña, H. A. (2017) · Oncotarget · doi:10.18632/oncotarget.23131 · Cited by 133
Roengvoraphoj, M., Tsongalis, G. J., Dragnev, K. H., & Rigas, J. R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.05.001 · Cited by 132
Perkins, G., Lu, H., Garlan, F., & Taly, V. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.10.001 · Cited by 132
Seremet, T., Jansen, Y. J. L., Planken, S., Njimi, H., Delaunoy, M., Housni, H. E., Awada, G., Schwarze, J. K., Keyaerts, M., Everaert, H., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2051-8 · Cited by 132
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
Hench, I. B., Hench, J., & Tolnay, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00009 · Cited by 128
Targeting BRAF mutations in non-small cell lung cancer
O’Leary, C. G., Andelkovic, V., Ladwa, R., Pavlakis, N., Zhou, C., Hirsch, F. R., Richard, D. J., & O'Byrne, K. J. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.10.22 · Cited by 110
Grölz, D., Hauch, S., Schlumpberger, M., Günther, K., Voß, T., Sprenger‐Haussels, M., & Oelmüller, U. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0180-z · Cited by 102
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC
Dagogo‐Jack, I., Rooney, M. M., Nagy, R. J., Lin, J. J., Chin, E. N., Ferris, L. A., Ackil, J., Lennerz, J. K., Lanman, R. B., Gainor, J. F., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.01.009 · Cited by 102
Li, Y., Pan, W., Connolly, I. D., Reddy, S. A., Nagpal, S., Quake, S. R., & Gephart, M. H. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2081-5 · Cited by 101
Okajima, W., Komatsu, S., Ichikawa, D., Miyamae, M., Ohashi, T., Imamura, T., Kiuchi, J., Nishibeppu, K., Arita, T., Konishi, H., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i31.5650 · Cited by 101
Re, M. D., Vivaldi, C., Rofi, E., Vasile, E., Miccoli, M., Caparello, C., d’Arienzo, P. D., Fornaro, L., Falcone, A., & Danesi, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-08297-z · Cited by 98
Review: Microfluidics technologies for blood-based cancer liquid biopsies
Sun, Y., Haglund, T. A., Rogers, A. J., Ghanim, A. F., & Sethu, P. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.12.050 · Cited by 97
Blood-based biomarkers for the diagnosis and monitoring of gliomas
Zachariah, M. A., Oliveira–Costa, J. P., Carter, B. S., Stott, S. L., & Nahed, B. V. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy074 · Cited by 97
Mair, R. J., Mouliere, F. C., Smith, C. G., Chandrananda, D., Gale, D. G., Marass, F., Tsui, D. W. Y., Massie, C. E., Wright, A. J., Watts, C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0074 · Cited by 97
Metabolic DNA as the Origin of Spontaneously Released DNA?
Gahan, P. B., Anker, P., & Stroun, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.046 · Cited by 94
Cancer DNA in the Circulation: The Liquid Biopsy
Husain, H., & Velculescu, V. E. (2017) · JAMA · doi:10.1001/jama.2017.12131 · Cited by 94
Klempner, S. J., Bazhenova, L. A., Braiteh, F. S., Nikolinakos, P. G., Gowen, K. A., Cervantes, C. M., Chmielecki, J., Greenbowe, J. R., Ross, J. S., Stephens, P. J., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.06.021 · Cited by 91
Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis
Gao, Y., Zhang, K., Xi, H., Cai, A., Wu, X., Cui, J., Li, J., Qiao, Z., Wei, B., & Chen, L. (2016) · Oncotarget · doi:10.18632/oncotarget.14064 · Cited by 90
Kim, S. T., Lee, W.-S., Lanman, R. B., Mortimer, S., Zill, O. A., Kim, S. H., Jang, K. T., Kim, S.-H., Park, S. H., Park, J. O., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5465 · Cited by 89
Zugazagoitia, J., Ramos, I. C., Trigo, J. M., Palka, M., Gómez‐Rueda, A., Lewintre, E. J., Camps, C., Isla, D., Iranzo, P., Ponce-Aix, S., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy512 · Cited by 89
Osumi, H., Shinozaki, E., Takeda, Y., Wakatsuki, T., Ichimura, T., Saiura, A., Yamaguchi, K., Takahashi, S., Noda, T., & Zembutsu, H. (2018) · Cancer Medicine · doi:10.1002/cam4.1913 · Cited by 87
Cell‐free tumour DNA testing for early detection of cancer – a potential future tool
Barbany, G., Arthur, C., Liedén, A., Nordenskjöld, M., Rosenquist, R., Tesi, B., Wallander, K., & Tham, E. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12897 · Cited by 87
Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA
Supplee, J., Milan, M. S. D., Lim, L. P., Potts, K. T., Sholl, L. M., Oxnard, G. R., & Paweletz, C. P. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.06.004 · Cited by 85
Rich, T. A., Reckamp, K. L., Chae, Y. K., Doebele, R. C., Iams, W. T., Oh, M. S., Raymond, V. M., Lanman, R. B., Riess, J. W., Stinchcombe, T. E., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4049 · Cited by 85
Bhangu, J. S., Beer, A., Mittlböck, M., Tamandl, D., Pulverer, W., Schönthaler, S., Taghizadeh, H., Stremitzer, S., Kaczirek, K., Gruenberger, T., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002901 · Cited by 83
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Cheng, X., Zhang, L., Chen, Y., & Qing, C. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0369-5 · Cited by 80
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology
Ponti, G., Manfredini, M., & Tomasi, A. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.06.005 · Cited by 78
Liquid biopsy tracking of lung tumor evolutions over time
Russo, A., de Miguel‐Pérez, D., Gunasekaran, M., Scilla, K. A., Lapidus, R. S., Cooper, B., Mehra, R., Adamo, V., Malapelle, U., & Rolfo, C. D. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1680287 · Cited by 78
Blons, H., Garinet, S., Laurent‐Puig, P., & Oudart, J. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.48 · Cited by 76
Perdomo, S. P., Avogbe, P. H., Foll, M., Abedi‐Ardekani, B., Facciolla, V. L., Anantharaman, D., Chopard, P., Calvez‐Kelm, F. L., Vilensky, M., Polesel, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20004 · Cited by 75
Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
Туаева, Н. О., Falzone, L., Porozov, Y. B., Nosyrev, A. E., Трухан, В. М., Kovatsi, L., Spandidos, D. A., Drakoulis, N., Kalogeraki, A. M., Mamoulakis, C., et al. (2019) · Cells · doi:10.3390/cells8101251 · Cited by 74
Pishvaian, M. J., Bender, R. J., Matrisian, L. M., Rahib, L., Hendifar, A. E., Hoos, W. A., Mikhail, S., Chung, V. M., Picozzi, V. J., Heartwell, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13225 · Cited by 72
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
Finotti, A., Allegretti, M., Gasparello, J., Giacomini, P., Spandidos, D. A., Spoto, G., & Gambari, R. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4516 · Cited by 71
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma
Piciocchi, M., Cardin, R., Vitale, A., Vanin, V., Giacomin, A., Pozzan, C., Maddalo, G., Cillo, U., Guido, M., & Farinati, F. (2013) · Hepatology International · doi:10.1007/s12072-013-9481-9 · Cited by 69
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
Yin, C., Yuan, C., Qu, Z., Guan, Q., Chen, H., & Wang, F. (2016) · Disease Markers · doi:10.1155/2016/1427849 · Cited by 69
Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids
Tsujiura, M., Ichikawa, D., Konishi, H., Komatsu, S., Shiozaki, A., & Otsuji, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i12.3265 · Cited by 68
Liquid biopsy in pancreatic cancer: the beginning of a new era
Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 68
Campone, M., Im, S., Iwata, H., Clemons, M. J., Ito, Y., Awada, A. H., Chia, S., Jagiełło-Gruszfeld, A., Pistilli, B., Tseng, L., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.08.002 · Cited by 66
New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
Russo, A., Lopes, A. R., McCusker, M. G., Garrigues, S. G., Ricciardi, G. R. R., Arensmeyer, K. E., Scilla, K. A., Mehra, R., & Rolfo, C. D. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00909-8 · Cited by 65
Shoda, K., Masuda, K., Ichikawa, D., Arita, T., Miyakami, Y., Watanabe, M., Konishi, H., Imoto, I., & Otsuji, E. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0432-5 · Cited by 64
Tumor DNA: an emerging biomarker in head and neck cancer
Bellairs, J. A., Hasina, R., & Agrawal, N. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9685-x · Cited by 63
Juric, D., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H., Iwata, H., Conte, P., Mayer, I., Kaufman, B., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.sabcs18-gs3-08 · Cited by 62
Multiparametric liquid biopsy analysis in metastatic prostate cancer
Hodara, E., Morrison, G. J., Cunha, A. T., Zainfeld, D. E., Xu, T., Xu, Y., Dempsey, P. W., Pagano, P. C., Bischoff, F. Z., Khurana, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125529 · Cited by 62
The Significance of Liquid Biopsy in Pancreatic Cancer
Qi, Z.-H., Xu, H., Zhang, S.-R., Xu, J.-Z., Li, S., Gao, H.-L., Jin, W., Wang, W.-Q., Wu, C., Ni, Q., et al. (2018) · Journal of Cancer · doi:10.7150/jca.24591 · Cited by 61
Vitiello, P. P., Falco, V. D., Giunta, E. F., Ciardiello, D., Cardone, C., Vitale, P., Zanaletti, N., Borrelli, C., Poliero, L., Terminiello, M., et al. (2019) · Cancers · doi:10.3390/cancers11101504 · Cited by 60
Vallée, A., Loupp, A.-G. L., & Denis, M. G. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.11.014 · Cited by 59
Steffensen, K. D., Madsen, C. V., Andersen, R. F., Waldstrøm, M., Adimi, P., & Jakobsen, A. K. M. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.022 · Cited by 59
Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
Pantel, K. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002205 · Cited by 56
Genetic profiling of cancer with circulating tumor DNA analysis
Lu, L., Bi, J., & Bao, L. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.11.006 · Cited by 56
Pritchett, M. A., Camidge, D. R., Patel, M., Khatri, J., Boniol, S., Friedman, E. K., Khomani, A., Dalia, S. M., Baker-Neblett, K. L., Plagnol, V., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00299 · Cited by 56
Liquid biopsy and its role in an advanced clinical trial for lung cancer
Johann, D. J., Steliga, M. A., Shin, I. J., Yoon, D., Arnaoutakis, K., Hutchins, L. F., Liu, M., Liem, J., Walker, K., Pereira, A., et al. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217750087 · Cited by 55
Remón, J., Lacroix, L., Jovelet, C., Caramella, C., Howarth, K., Plagnol, V., Rosenfeld, N., Morris, C. D., Mezquita, L., Pannet, C., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00211 · Cited by 55
Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors
Goranova, T., Ohue, M., Shimoharu, Y., & Kato, K. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9381-0 · Cited by 53
González‐Billalabeitia, E., Conteduca, V., Wetterskog, D., Jayaram, A., & Attard, G. (2018) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0098-x · Cited by 51
Detection of EGFR Variants in Plasma
Keppens, C., Palma, J. F., Das, P. M., Scudder, S., Wen, W. X., Normanno, N., van Krieken, J. H., Sacco, A., Fenizia, F., de Castro, D. G., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.03.006 · Cited by 50
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S., & Pretorius, P. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2370-3 · Cited by 49
The current status of the clinical utility of liquid biopsies in cancer
Snow, A. E., Chen, D., & Lang, J. E. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1664290 · Cited by 48
Precision medicine for gastrointestinal cancer: Recent progress and future perspective
Matsuoka, T., & Yashiro, M. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i1.1 · Cited by 48
Liquid biopsies for hepatocellular carcinoma
Su, Y., Kim, A. K., & Jain, S. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.001 · Cited by 47
Liquid biopsy: novel technologies and clinical applications
Reimers, N., & Pantel, K. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0610 · Cited by 47
Significance of Liquid Biopsy for Monitoring and Therapy Decision of Colorectal Cancer
Klein‐Scory, S., Maslova, M., Pohl, M., Eilert-Micus, C., Schroers, R., Schmiegel, W., & Baraniskin, A. (2018) · Translational Oncology · doi:10.1016/j.tranon.2017.12.010 · Cited by 46
Deans, Z. C., Butler, R., Cheetham, M. H., Dequeker, E. M. C., Fairley, J. A., Fenizia, F., Hall, J. A., Keppens, C., Normanno, N., Schuuring, E. M. D., et al. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02571-3 · Cited by 45
Lyskjær, I., Kronborg, C. J. S., Rasmussen, M. H., Sørensen, B. S., Demuth, C., Rosenkilde, M., Frydendahl, A., Knudsen, M., Vang, S., Krag, S. R. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47708-1 · Cited by 44
The liquid biopsy in lung cancer
Ansari, J., Yun, J. W., Kompelli, A. R., Moufarrej, Y. E., Alexander, J. S., Herrera, G. A., & Shackelford, R. E. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.127 · Cited by 41
Ma, X., Zhu, L., Wu, X., Bao, H., Wang, X., Chang, Z., Shao, Y. W., & Wang, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169231 · Cited by 40
Technical considerations for circulating tumor DNA detection in oncology
Franczak, C., Filhine-Trésarrieu, P., Gilson, P., Merlin, J., Au, L., & Harlé, A. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1568873 · Cited by 40
Challenges in Using ctDNA to Achieve Early Detection of CancerPreprint
Haque, I. S., & Elemento, O. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/237578 · Cited by 39
Li, G., Pavlick, D. C., Chung, J., Bauer, T. M., Tan, B. A., Peguero, J., Ward, P. J., Kallab, A. M., Bufill, J. A., Hoffman, A. D., et al. (2019) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2019.05.05 · Cited by 38
Remón, J., García‐Campelo, R., de Álava, E., Vera, R., Rodríguez‐Peralto, J. L., Rodríguez-Lescure, Á., Bellosillo, B., Garrido, P., Rojo, F., & Álvarez-Alegret, R. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02211-x · Cited by 37
Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
Payne, K. F. B., Brooks, J. M., Spruce, R. J., Batis, N., Taylor, G. S., Nankivell, P., & Mehanna, H. M. (2019) · Cancers · doi:10.3390/cancers11081115 · Cited by 32
Mezzalira, S., Mattia, E. D., Guardascione, M., Fratte, C. D., Cecchin, E., & Toffoli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215498 · Cited by 32
Feasibility of circulating tumor DNA testing in hepatocellular carcinoma
Mody, K., Kasi, P. M., Yang, J. D., Surapaneni, P. K., Ritter, A., Roberts, A., Nagy, R. J., & Borad, M. J. (2019) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2019.02.10 · Cited by 30
Yoshinami, T., Kagara, N., Motooka, D., Nakamura, S., Miyake, T., Tanei, T., Naoi, Y., Shimoda, M., Shimazu, K., Kim, S. J., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100787 · Cited by 28
Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine
Kerachian, M. A., Poudineh, A., & Thiery, J. P. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102827 · Cited by 27
Bertero, L., Siravegna, G., Rudà, R., Soffietti, R., Bardelli, A., & Cassoni, P. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12553 · Cited by 25
Cui, S., Ye, L., Wang, H., Chu, T., Zhao, Y., Gu, A., Xiong, L., Shi, C., & Jiang, L. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.12.009 · Cited by 24
Kastrisiou, M., Zarkavelis, G., Pentheroudakis, G. E., & Magklara, A. (2019) · Cancers · doi:10.3390/cancers11101573 · Cited by 24
Liu, J., Xie, L., Cheng, L., Qian, X., Liu, B., Hu, J. Y., Ren, W., & Yang, M. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s86966 · Cited by 23
Ying, M., Zhu, X., Yang, Z., Li, D.-H., & Chen, L. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.10.4439 · Cited by 23
Cited by
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Das, S., Dey, M. K., Devireddy, R., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 383
Circulating tumour DNA — looking beyond the blood
Tivey, A., Church, M., Rothwell, D., Dive, C., & Cook, N. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00660-y · Cited by 321
Molecular Biomarkers for the Early Detection of Ovarian Cancer
Zhang, R., Siu, M. K. Y., Ngan, H. Y. S., & Chan, K. K. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231912041 · Cited by 283
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wang, W., Lian, B., Xu, C., Wang, Q., Li, Z., Zheng, N., Liu, A., Yu, J., Zhong, W., Wang, Z., et al. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100661 · Cited by 14
Metadata
- Authors
- Pessoa, L. S., Heringer, M., & Ferrer, V. P.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 155
- Pages
- 103109
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W3036135178
- Cited by
- 298
- References
- 211
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.